Research ArticleImages in Rheumatology
Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-γ Antibody
Mina Z. Al Awqati, Jason C. Sluzevich and Florentina Berianu
The Journal of Rheumatology June 2021, jrheum.200399; DOI: https://doi.org/10.3899/jrheum.200399
Mina Z. Al Awqati
Division of Rheumatology, Mayo Clinic; Department of Dermatology, Mayo Clinic; Division of Rheumatology, Mayo Clinic, Jacksonville, Florida, USA. The authors declare no conflicts of interest. Patient consent was obtained. Institutional review board approval was not required according to the authors' institution. Address correspondence to Dr. F. Berianu, Division of Rheumatology, Mayo Clinic, 4500 San Pablo Rd., Jacksonville, FL 32224, USA. Email: Berianu.Florentina@mayo.edu.
Jason C. Sluzevich
Division of Rheumatology, Mayo Clinic; Department of Dermatology, Mayo Clinic; Division of Rheumatology, Mayo Clinic, Jacksonville, Florida, USA. The authors declare no conflicts of interest. Patient consent was obtained. Institutional review board approval was not required according to the authors' institution. Address correspondence to Dr. F. Berianu, Division of Rheumatology, Mayo Clinic, 4500 San Pablo Rd., Jacksonville, FL 32224, USA. Email: Berianu.Florentina@mayo.edu.
Florentina Berianu
Division of Rheumatology, Mayo Clinic; Department of Dermatology, Mayo Clinic; Division of Rheumatology, Mayo Clinic, Jacksonville, Florida, USA. The authors declare no conflicts of interest. Patient consent was obtained. Institutional review board approval was not required according to the authors' institution. Address correspondence to Dr. F. Berianu, Division of Rheumatology, Mayo Clinic, 4500 San Pablo Rd., Jacksonville, FL 32224, USA. Email: Berianu.Florentina@mayo.edu.
Abstract
Dermatomyositis (DM) is an autoimmune inflammatory disease of the skin with or without muscle involvement1. One-third of patients present with malignant disease within 3 years2.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-γ Antibody
Mina Z. Al Awqati, Jason C. Sluzevich, Florentina Berianu
The Journal of Rheumatology Jun 2021, jrheum.200399; DOI: 10.3899/jrheum.200399